Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. YOUNG AA; VINE W; GEDULIN BR; PITTNER R; JANES S; GAETA LSL; PERCY A; MOORE CX; KODA JE; RINK TJ; BEAUMONT K
   PRECLINICAL PHARMACOLOGY OF PRAMLINTIDE IN THE RAT - COMPARISONS WITHHUMAN AND RAT AMYLIN
   Drug development research
   
   A.A. Young et al., "PRECLINICAL PHARMACOLOGY OF PRAMLINTIDE IN THE RAT - COMPARISONS WITHHUMAN AND RAT AMYLIN", Drug development research, 37(4), 1996, pp. 231-248
2. BEAUMONT K; MOORE CX; PITTNER RA; PRICKETT KS; GAETA LSL; RINK TJ; YOUNG AA
   DIFFERENTIAL ANTAGONISM OF AMYLINS METABOLIC AND VASCULAR ACTIONS WITH AMYLIN RECEPTOR ANTAGONISTS
   Canadian journal of physiology and pharmacology
   
   K. Beaumont et al., "DIFFERENTIAL ANTAGONISM OF AMYLINS METABOLIC AND VASCULAR ACTIONS WITH AMYLIN RECEPTOR ANTAGONISTS", Canadian journal of physiology and pharmacology, 73(7), 1995, pp. 1025-1029
3. PITTNER RA; ALBRANDT K; BEAUMONT K; GAETA LSL; KODA JE; MOORE CX; RITTENHOUSE J; RINK TJ
   MOLECULAR PHYSIOLOGY OF AMYLIN
   Journal of cellular biochemistry
   
   R.A. Pittner et al., "MOLECULAR PHYSIOLOGY OF AMYLIN", Journal of cellular biochemistry, 55, 1994, pp. 19-28
4. YOUNG AA; GEDULIN B; GAETA LSL; PRICKETT KS; BEAUMONT K; LARSON E; RINK TJ
   SELECTIVE AMYLIN ANTAGONIST SUPPRESSES RISE IN PLASMA LACTATE AFTER INTRAVENOUS GLUCOSE IN THE RAT - EVIDENCE FOR A METABOLIC ROLE OF ENDOGENOUS AMYLIN
   FEBS letters
   
   A.A. Young et al., "SELECTIVE AMYLIN ANTAGONIST SUPPRESSES RISE IN PLASMA LACTATE AFTER INTRAVENOUS GLUCOSE IN THE RAT - EVIDENCE FOR A METABOLIC ROLE OF ENDOGENOUS AMYLIN", FEBS letters, 343(3), 1994, pp. 237-241
5. BEAUMONT K; MOORE CX; PITTNER R; PRICKETT K; GAETA LSL; RINK TJ; YOUNG AA
   DIFFERENTIAL PHARMACOLOGICAL ANTAGONISM OF AMYLIN AND CGRP RECEPTORS
   Diabetologia
   
   K. Beaumont et al., "DIFFERENTIAL PHARMACOLOGICAL ANTAGONISM OF AMYLIN AND CGRP RECEPTORS", Diabetologia, 37, 1994, pp. 10000116-10000116
6. CORT J; LIU ZH; LEE G; HARRIS SM; PRICKETT KS; GAETA LSL; ANDERSEN NH
   BETA-STRUCTURE IN HUMAN AMYLIN AND 2 DESIGNER BETA-PEPTIDES - CD AND NMR SPECTROSCOPIC COMPARISONS SUGGEST SOLUBLE BETA-OLIGOMERS AND THE ABSENCE OF SIGNIFICANT POPULATIONS OF BETA-STRAND DIMERS
   Biochemical and biophysical research communications
   
   J. Cort et al., "BETA-STRUCTURE IN HUMAN AMYLIN AND 2 DESIGNER BETA-PEPTIDES - CD AND NMR SPECTROSCOPIC COMPARISONS SUGGEST SOLUBLE BETA-OLIGOMERS AND THE ABSENCE OF SIGNIFICANT POPULATIONS OF BETA-STRAND DIMERS", Biochemical and biophysical research communications, 204(3), 1994, pp. 1088-1095
7. BEAUMONT K; KENNEY MA; WOLFELOPEZ D; ALBRECHT EA; GAETA LSL
   A RECEPTOR ANTAGONIST SELECTIVE FOR AMYLIN OVER CGRP BLOCKS AMYLINS METABOLIC ACTIONS
   Diabetes
   
   K. Beaumont et al., "A RECEPTOR ANTAGONIST SELECTIVE FOR AMYLIN OVER CGRP BLOCKS AMYLINS METABOLIC ACTIONS", Diabetes, 42, 1993, pp. 215-215